| BSE: 530125 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE103E01016 |
| BSE 09:34 | 18 Feb | 81.80 |
0.70 (0.86%) |
OPEN
88.40 |
HIGH
88.40 |
LOW
81.80 |
| NSE 05:30 | 01 Jan | Samrat Pharmachem Ltd |
| OPEN | 88.40 |
| PREVIOUS CLOSE | 81.10 |
| VOLUME | 157 |
| 52-Week high | 132.00 |
| 52-Week low | 47.50 |
| P/E | 4.91 |
| Mkt Cap.(Rs cr) | 25 |
| Buy Price | 79.00 |
| Buy Qty | 36.00 |
| Sell Price | 83.85 |
| Sell Qty | 30.00 |
Samrat Pharmachem Ltd is planning to de-merge its Second Unit in favour of newly formed company viz. Samrat Remedies Ltd w.e.f. April 1, 2004....> More
| COMPANY INFORMATION | |||||||
| Chairman & Managing Director : | Lalit Mehta | ||||||
| Director : | Rajesh Mehta | ||||||
| Independent Director : | Mahendra Pipalia | ||||||
| Independent Director : | Samir Kothary | ||||||
| Independent Director : | Renu P Dharod | ||||||
| Director : | Megh Mehta | ||||||
| Company Secretary : | Sandeep Prajapati | ||||||
| AUDITOR : | Shah & Savla LLP | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| Plot No A2/3445, GIDC Phase IV,Ankleshwar,Gujarat-393002 | |||||||
| Ph : 91-2646-220774 | |||||||
| WEBSITE : http://www.samratpharmachem.com | |||||||
| E-mail : samrat@bom4.vsnl.net.in | |||||||
